Residency · Greenville, SC
Sponsored by Prisma Health
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
The New England journal of medicine · 2023 · 703 citations · Sarah Gill
Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial.
Annals of oncology : official journal of the European Society for Medical Oncology · 2024 · 109 citations · Sarah Gill
A systematic review of interventions to promote HPV vaccination globally.
BMC public health · 2023 · 69 citations · Meena Dhir
Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Early Pregnancy: The MOMPOD Randomized Clinical Trial.
JAMA · 2023 · 67 citations · Kacey Eichelberger
Remote Monitoring Compared With In-Office Surveillance of Blood Pressure in Patients With Pregnancy-Related Hypertension: A Randomized Controlled Trial.
Obstetrics and gynecology · 2023 · 36 citations · Brittany Arkerson, Renata Sawyer
Extravillous trophoblast cell lineage development is associated with active remodeling of the chromatin landscape.
Nature communications · 2023 · 53 citations ·
Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).
Gynecologic oncology · 2025 · 22 citations · Sarah Gill
Group vs traditional prenatal care for improving racial equity in preterm birth and low birthweight: the Centering and Racial Disparities randomized clinical trial study.
American journal of obstetrics and gynecology · 2022 · 36 citations · Amy Crockett